Researchers from Polytechnique Montréal, Université de Montréal, and McGill University have designed a new cancer-drug-delivery nanotransporter system using more than 100 million flagellated, self-propelled bacteria that are capable of navigating through the bloodstream to administer a drug to tumors with precision.* The goal of the research is to avoid jeopardizing the integrity of organs and surrounding healthy tissues while reducing drug dosage.Read more here.
Thursday, August 18, 2016
New cancer-drug delivery system
Kurzweil Accelerating Intelligence reports that the system uses magnetically guided bacteria to target cancerous tumors with high precision:
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment